Citations (319)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Stephanie Sally Fong, Yiing Yee Foo, Wen Shang Saw, Bey Fen Leo, Yin Yin Teo, Ivy Chung, Boon Tong Goh, Misni Misran, Toyoko Imae, Chia-Ching Chang, Lip Yong Chung & Lik Voon Kiew. (2022) Chitosan-Coated-PLGA Nanoparticles Enhance the Antitumor and Antimigration Activity of Stattic – A STAT3 Dimerization Blocker. International Journal of Nanomedicine 17, pages 137-150.
Read now
Read now
Houfang Sun, Sheng Wei & Lili Yang. (2019) Dysfunction of immune system in the development of large granular lymphocyte leukemia. Hematology 24:1, pages 139-147.
Read now
Read now
SM Mirnoori, SS Shahangian, Zivar Salehi, F Mashayekhi, S Talesh Sasani & HS Saedi. (2018) Influence of single nucleotide polymorphisms in pri-miR-124-1 and STAT3 genes on gastric cancer susceptibility. British Journal of Biomedical Science 75:4, pages 182-186.
Read now
Read now
Rubashruti Kanna, Gaurav Choudhary, Nandini Ramachandra, Ulrich Steidl, Amit Verma & Aditi Shastri. (2018) STAT3 inhibition as a therapeutic strategy for leukemia. Leukemia & Lymphoma 59:9, pages 2068-2074.
Read now
Read now
Xiao-hu Nie, Jia Ou-yang, Ying Xing, Dan-yan Li, Xing-yu Dong, Ru-en Liu & Ru-xiang Xu. (2015) Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin–proteasome pathway. Drug Design, Development and Therapy 9, pages 5611-5622.
Read now
Read now
Daniel J. Garama, Tiffany J. Harris, Christine L. White, Fernando J. Rossello, Maher Abdul-Hay, Daniel J. Gough & David E. Levy. (2015) A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3. Molecular and Cellular Biology 35:21, pages 3646-3656.
Read now
Read now
Matteo Santoni, Francesco Massari, Marzia Del Re, Chiara Ciccarese, Francesco Piva, Giovanni Principato, Rodolfo Montironi, Daniele Santini, Romano Danesi, Giampaolo Tortora & Stefano Cascinu. (2015) Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer. Expert Opinion on Investigational Drugs 24:6, pages 809-824.
Read now
Read now
Narinder Kumar Sharma, Sharmila Shankar & Rakesh K Srivastava. (2014) STAT3 as an emerging molecular target in pancreatic cancer. Gastrointestinal Cancer: Targets and Therapy 4, pages 115-122.
Read now
Read now
Antonio Lavecchia, Carmen Di Giovanni & Carmen Cerchia. (2014) Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature. Expert Opinion on Therapeutic Patents 24:4, pages 383-400.
Read now
Read now
Lior H Katz, Ying Li, Jiun-Sheng Chen, Nina M Muñoz, Avijit Majumdar, Jian Chen & Lopa Mishra. (2013) Targeting TGF-β signaling in cancer. Expert Opinion on Therapeutic Targets 17:7, pages 743-760.
Read now
Read now
Remi Fagard, Valeri Metelev, Inès Souissi & Fanny Baran-Marszak. (2013) STAT3 inhibitors for cancer therapy. JAK-STAT 2:1.
Read now
Read now
Olga A. Timofeeva & Nadya I. Tarasova. (2012) Alternative ways of modulating JAK-STAT pathway. JAK-STAT 1:4, pages 274-284.
Read now
Read now
Malabika Sen & Jennifer R. Grandis. (2012) Nucleic acid-based approaches to STAT inhibition. JAK-STAT 1:4, pages 285-291.
Read now
Read now
Andrew S Giraud, Trevelyan R Menheniott & Louise M Judd. (2012) Targeting STAT3 in gastric cancer. Expert Opinion on Therapeutic Targets 16:9, pages 889-901.
Read now
Read now
Corina Borghouts, Natalia Delis, Boris Brill, Astrid Weiss, Laura Mack, Peter Lucks & Bernd Groner. (2012) A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cells. JAK-STAT 1:1, pages 44-55.
Read now
Read now
Brent DG Page, Daniel P Ball & Patrick T Gunning. (2011) Signal transducer and activator of transcription 3 inhibitors: a patent review. Expert Opinion on Therapeutic Patents 21:1, pages 65-83.
Read now
Read now
Articles from other publishers (303)
Shao-Qian Sun, Feng-Xiang Du, Li-Hua Zhang, Hao-Shi, Fu-Ying Gu, Yu-Lin Deng & Yi-Zhi Ji. (2023) Prevention of STAT3-related pathway in SK-N-SH cells by natural product astaxanthin. BMC Complementary Medicine and Therapies 23:1.
Crossref
Crossref
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, Nafisesadat Amini, Kasra Talebi Anaraki, Motahhar Motahhary, Ensi Khalilipouya, Abdorrahman Harif Nashtifani, Sasan Shafiei, Marzieh Ramezani Farani, Noushin Nabavi, Shokooh Salimimoghadam, Amir Reza Aref, Rasoul Raesi, Afshin Taheriazam, Maliheh Entezari & Wenliang Zha. (2023) STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies. Environmental Research 233, pages 116458.
Crossref
Crossref
Priyanka Joshi, Kanika Verma, Deepak Kumar Semwal, Jaya Dwivedi & Swapnil Sharma. (2023) Mechanism insights of curcumin and its analogues in cancer: An update. Phytotherapy Research.
Crossref
Crossref
Salwa Bouabdallah, Amna Al-Maktoum & Amr Amin. (2023) Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer. Cancers 15:15, pages 3900.
Crossref
Crossref
Suryaa Manoharan, Ajithkumar Balakrishnan, Vedagiri Hemamalini & Ekambaram Perumal. (2022) Screening of potent STAT3-SH2 domain inhibitors from JAK/STAT compound library through molecular dynamics simulation. Molecular Diversity 27:3, pages 1297-1308.
Crossref
Crossref
Mia C. Borlongan & Hongbin Wang. (2023) Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, Maliheh Entezari, Mahsa Mojtabavi, Behnaz Raei, Mohammad Arad Zandieh, Mitra Behroozaghdam, Sepideh Mirzaei, Kiavash Hushmandi, Noushin Nabavi, Shokooh Salimimoghadam, Jun Ren, Mohsen Rashidi, Rasoul Raesi, Afshin Taheriazam, Athanasios Alexiou, Marios Papadakis & Shing Cheng Tan. (2023) Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. Cellular & Molecular Biology Letters 28:1.
Crossref
Crossref
Haolong Ding, Qianwen Ouyang, Xiaochen Jiang & Xiaobo Wu. (2023) Brefeldin A-ester targets breast cancer cell proliferation, invasion and migration through targeting STAT3 protein expression. Phytochemistry Letters 53, pages 60-65.
Crossref
Crossref
Fatma Betül Arslan, Kıvılcım Öztürk, Ece Tavukçuoğlu, Süleyman Can Öztürk, Güneş Esendağlı & Sema Çalış. (2023) A novel combination for the treatment of small cell lung cancer: Active targeted irinotecan and stattic co-loaded PLGA nanoparticles. International Journal of Pharmaceutics 632, pages 122573.
Crossref
Crossref
WEI XIA, NING YANG, XIAOYAN FENG, TING XIN, YONGLE JING, YUMING LI & CHENGZHI LU. (2023) UCK2 promotes the proliferation, migration, and invasion of trophoblast cells in preeclampsia by activating the STAT3 pathway. BIOCELL 47:4, pages 837-847.
Crossref
Crossref
Jamie V. Shiah, Daniel E. Johnson & Jennifer R. Grandis. (2023) Transcription Factors and Cancer. The Cancer Journal 29:1, pages 38-46.
Crossref
Crossref
Syeda Mobeen Anjum, Katari Sudheer Kumar, Amineni Umamaheswari, Dinesh Lakhanpal, Sandeep Swargam, Khateef Riazunnisa & Thummala Chandrasekhar. (2023) Identification of a natural antagonist for signal transducer and activator of transcription 3 (STAT3) by computational approach. Results in Chemistry 5, pages 100970.
Crossref
Crossref
Xiao-Hu Nie, Sheng Qiu, Ying Xing, Jie Xu, Bin Lu, Shu-Fa Zhao, Yun-Tao Li & Zhong-Zhou Su. (2022) Paeoniflorin Regulates NEDD4L/STAT3 Pathway to Induce Ferroptosis in Human Glioma Cells. Journal of Oncology 2022, pages 1-15.
Crossref
Crossref
Jinmei Jin, Yaping Wu, Zeng Zhao, Ye Wu, Yu-dong Zhou, Sanhong Liu, Qingyan Sun, Guizhu Yang, Jiayi Lin, Dale G. Nagle, Jiangjiang Qin, Zhiyuan Zhang, Hong-zhuan Chen, Weidong Zhang, Shuyang Sun & Xin Luan. (2022) Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer. JCI Insight 7:22.
Crossref
Crossref
Abdul Wadood, Amar Ajmal, Muhammad Junaid, Ashfaq Ur Rehman, Reaz Uddin, Syed Sikander Azam, Alam Zeb Khan & Asad Ali. (2022) Machine Learning-based Virtual Screening for STAT3 Anticancer Drug Target. Current Pharmaceutical Design 28:36, pages 3023-3032.
Crossref
Crossref
Elnaz Faghfuri, Mohsen Sagha & Amir Hossein Faghfouri. (2021) The Cytotoxicity Effect of Curcumin Loaded Folic Acid Conjugated-Nanoparticles on Breast Cancer Cells and Its Association with Inhibition of STAT3 Phosphorylation. Journal of Cluster Science 33:5, pages 2037-2044.
Crossref
Crossref
Kenichi Kobayashi, Hiroshi Kogen & Osamu Tamura. (2022) Total Synthesis of Phaeosphaerides with STAT3 Inhibitory ActivitySTAT3阻害活性を有するPhaeosphaeride類の全合成. Journal of Synthetic Organic Chemistry, Japan 80:8, pages 755-765.
Crossref
Crossref
Elina Khatoon, Mangala Hegde, Aviral Kumar, Uzini Devi Daimary, Gautam Sethi, Anupam Bishayee & Ajaikumar B. Kunnumakkara. (2022) The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer. Archives of Pharmacal Research 45:8, pages 507-534.
Crossref
Crossref
Yan Zhong, Lin Deng, Shuo Shi, Qiu-yao Huang, Shu-min Ou-Yang, Jian-shan Mo, Kai Zhu, Xin-ming Qu, Pei-qing Liu, Yuan-xiang Wang & Xiao-lei Zhang. (2021) The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts. Acta Pharmacologica Sinica 43:4, pages 1013-1023.
Crossref
Crossref
Mohamed El-Tanani, Arwa Omar Al Khatib, Safwan Mahmoud Aladwan, Ahmed Abuelhana, Paul A. McCarron & Murtaza M. Tambuwala. (2022) Importance of STAT3 signalling in cancer, metastasis and therapeutic interventions. Cellular Signalling 92, pages 110275.
Crossref
Crossref
Erum Zafar, Muhammad Faisal Maqbool, Asia Iqbal, Amara Maryam, Hafiz Abdullah Shakir, Muhammad Irfan, Muhammad Khan, Yongming Li & Tonghui Ma. (2021) A comprehensive review on anticancer mechanism of bazedoxifene. Biotechnology and Applied Biochemistry 69:2, pages 767-782.
Crossref
Crossref
Jitender Bariwal, Hairong Ma, Guillermo A. Altenberg & Hongjun Liang. (2022) Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment. Chemical Society Reviews 51:5, pages 1702-1728.
Crossref
Crossref
Yee Chu Kwa, Theebaa Anasamy, Yiing Yee Foo, Bey Fen Leo, Ivy Chung, Lik Voon Kiew & Lip Yong Chung. (2022) Preparation and Characterization of Stattic-Loaded Albumin Nanoparticles
for Antimetastatic Cancer Treatment. Drug Delivery Letters 12:1, pages 74-83.
Crossref
Crossref
X. Shi, L. Shu, Y. Qiao, J. Yao, H. Xie, L. Zhou, H. Wang & S. Zheng. (2022) Synergistic nanoassemblies constructed from a STAT3 inhibitor and a cabazitaxel prodrug with enhanced cancer chemo-immunotherapy. Materials Today Nano 17, pages 100155.
Crossref
Crossref
Wuyang Yue, Xuxi Chen, Sifu He, Na Li, Lishi Zhang & Jinyao Chen. (2021) Exposure interval to ambient fine particulate matter (PM2.5) collected in Southwest China induced pulmonary damage through the Janus tyrosine protein kinase‐2/signal transducer and activator of transcription‐3 signaling pathway both in vivo and in vitro. Journal of Applied Toxicology 41:12, pages 2042-2054.
Crossref
Crossref
Mariia Radaeva, Anh-Tien Ton, Michael Hsing, Fuqiang Ban & Artem Cherkasov. (2021) Drugging the ‘undruggable’. Therapeutic targeting of protein–DNA interactions with the use of computer-aided drug discovery methods. Drug Discovery Today 26:11, pages 2660-2679.
Crossref
Crossref
Carlos Martínez-Pérez, Charlene Kay, James Meehan, Mark Gray, J. Michael Dixon & Arran K. Turnbull. (2021) The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer. Journal of Personalized Medicine 11:11, pages 1073.
Crossref
Crossref
Muhamad Mustafa, Amer Ali Abd El-Hafeez, Dalia A Abdelhafeez, Dalia Abdelhamid, Yaser A Mostafa, Pradipta Ghosh, Alaa M Hayallah & Gamal El-Din A Abuo-Rahma. (2021) FAK inhibitors as promising anticancer targets: present and future directions. Future Medicinal Chemistry 13:18, pages 1559-1590.
Crossref
Crossref
Bocheng Wu, Benny Payero, Sydney Taylor & Adegboyega K Oyelere. (2021) Discovery of novel STAT3 DNA binding domain inhibitors. Future Medicinal Chemistry 13:15, pages 1253-1269.
Crossref
Crossref
Abdollah Jafarzadeh, Maryam Nemati & Sara Jafarzadeh. (2021) Contribution of STAT3 to the pathogenesis of COVID-19. Microbial Pathogenesis 154, pages 104836.
Crossref
Crossref
Zilu Tian, Zhiyi Liu, Xiaokang Fang, Kuan Cao, Bin Zhang, Rui Wu, Xin Wen, Quan Wen, Hengliang Shi & Renhao Wang. (2021) ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1/STAT3 pathway. Carcinogenesis 42:3, pages 493-506.
Crossref
Crossref
Amir Sonnenblick, Dominique Agbor‐tarh, Evandro Azambuja, Susanne Hultsch, Miguel Izquierdo, Minetta Liu, Giancarlo Pruneri, Nadia Harbeck, Martine Piccart, Alvaro Moreno‐Aspita, Roy Zvi Granit, Ghizlane Rouas, Ibrahim Fahoum & Christos Sotiriou. (2020)
STAT3
activation in
HER2
‐positive breast cancers: Analysis of data from a large prospective trial
. International Journal of Cancer 148:6, pages 1529-1535.
Crossref
Crossref
Shuxiang Wu, Shuangshuang Ye, Xiaohan Lin, Yan Chen, Yi Zhang, Zhentang Jing, Wei Liu, Wannan Chen, Xinjian Lin & Xu Lin. (2021) Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling. Cancer Letters 499, pages 175-187.
Crossref
Crossref
Maryam Aftabizadeh, Yi-Jia Li, Qianqian Zhao, Chunyan Zhang, Nigus Ambaye, Jieun Song, Toshikage Nagao, Christoph Lahtz, Marwan Fakih, David K. Ann, Hua Yu & Andreas Herrmann. (2021) Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis. JCI Insight 6:2.
Crossref
Crossref
Christine Brotherton-Pleiss, Peibin Yue, Yinsong Zhu, Kayo Nakamura, Weiliang Chen, Wenzhen Fu, Casie Kubota, Jasmine Chen, Felix Alonso-Valenteen, Simoun Mikhael, Lali Medina-Kauwe, Marcus A. Tius, Francisco Lopez-Tapia & James Turkson. (2020) Discovery of Novel Azetidine Amides as Potent Small-Molecule STAT3 Inhibitors. Journal of Medicinal Chemistry 64:1, pages 695-710.
Crossref
Crossref
Zakia Akter, Faiza Rafa Ahmed, Mousumi Tania & Md. Asaduzzaman Khan. (2020) Targeting Inflammatory Mediators: An Anticancer Mechanism of Thymoquinone Action. Current Medicinal Chemistry 28:1, pages 80-92.
Crossref
Crossref
Nikita Aggarwal, Joni Yadav, Kulbhushan Thakur, Rakhi Bibban, Arun Chhokar, Tanya Tripathi, Anjali Bhat, Tejveer Singh, Mohit Jadli, Ujala Singh, Manoj K. Kashyap & Alok C. Bharti. (2020) Human Papillomavirus Infection in Head and Neck Squamous Cell Carcinomas: Transcriptional Triggers and Changed Disease Patterns. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Siphokazi Sinethemba Mtwebana & Earl Prinsloo. (2020) The commercially available STAT3 inhibitor 5,15-diphenylporphyrin (5,15-DPP) does not directly interact with STAT3 core residues 127–722. BMC Research Notes 13:1.
Crossref
Crossref
Lara Brambilla, Tanaya Lahiri, Michael Cammer & David E. Levy. (2020) STAT3 Inhibitor OPB-51602 Is Cytotoxic to Tumor Cells Through Inhibition of Complex I and ROS Induction. iScience 23:12, pages 101822.
Crossref
Crossref
Xiaodong Sun, Qianqian Xu, Lian Zeng, Lixia Xie, Qiang Zhao, Hongxia Xu, Xuanbin Wang, Nan Jiang, Pan Fu & Ming Sang. (2020)
Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3
Tyr705
phosphorylation
. Cancer Medicine 9:22, pages 8685-8700.
Crossref
Crossref
Sung-Jun Hong, Jin-Tae Kim, Su-Jung Kim, Nam-Chul Cho, Kyeojin Kim, Seungbeom Lee, Young-Ger Suh, Kyung-Cho Cho, Kwang Pyo Kim & Young-Joon Surh. (2020) An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target. Biomedicines 8:10, pages 407.
Crossref
Crossref
Claudia Rita Corso, Maria Carolina Stipp, Débora Rasec Radulski, Marihá Mariott, Luisa Mota da Silva, Edneia Amancio de Souza Ramos, Giseli Klassen, José Ederaldo Queiroz Telles, Cristhian Santos Oliveira, Maria Élida Alves Stefanello, Arthur J. Verhoeven, Ronald P. J. Oude Elferink & Alexandra Acco. (2020) Fruticuline A, a chemically-defined diterpene, exerts antineoplastic effects in vitro and in vivo by multiple mechanisms. Scientific Reports 10:1.
Crossref
Crossref
Yee Chu Kwa, Yuen Fen Tan, Yiing Yee Foo, Bey Fen Leo, Ivy Chung, Lik Voon Kiew, Toyoko Imae, Shin-ichi Yusa & Lip Yong Chung. (2020) Improved delivery and antimetastatic effects of Stattic by self-assembled amphiphilic pendant-dendron copolymer micelles in breast cancer cell lines. Journal of Drug Delivery Science and Technology 59, pages 101905.
Crossref
Crossref
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid & Mohamed Abdel-Aziz. (2020) STAT3 transcription factor as target for anti-cancer therapy. Pharmacological Reports 72:5, pages 1101-1124.
Crossref
Crossref
Anil Kumar Yadav & Byeong-Churl Jang. (2020) Anti-Survival and Pro-Apoptotic Effects of 6-Shogaol on SW872 Human Liposarcoma Cells via Control of the Intrinsic Caspase Pathway, STAT-3, AMPK, and ER Stress. Biomolecules 10:10, pages 1380.
Crossref
Crossref
Seung-Nam Jung, Yea Eun Kang, Gun Ho Lee, Lihua Liu, Chan Oh, Yan Li Jin, Mi Ae Lim, Kyungmin Lee, Taejeong Oh, Ho-Ryun Won, Jae Won Chang & Bon Seok Koo. (2020) Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism 105:9, pages e3127-e3141.
Crossref
Crossref
Grégory La Sala, Camille Michiels, Tim Kükenshöner, Tania Brandstoetter, Barbara Maurer, Akiko Koide, Kelvin Lau, Florence Pojer, Shohei Koide, Veronika Sexl, Laure Dumoutier & Oliver Hantschel. (2020) Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains. Nature Communications 11:1.
Crossref
Crossref
Shao-Qian Sun, You-Xi Zhao, Si-Yu Li, Jing-Wen Qiang & Yi-Zhi Ji. (2020) Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer. Marine Drugs 18:8, pages 415.
Crossref
Crossref
Tohid Gharibi, Zohreh Babaloo, Arezoo Hosseini, Meghdad Abdollahpour-alitappeh, Vida Hashemi, Faroogh Marofi, Kazem Nejati & Behzad Baradaran. (2020) Targeting STAT3 in cancer and autoimmune diseases. European Journal of Pharmacology 878, pages 173107.
Crossref
Crossref
Kaviarasan Lakshmanan, Gowramma Byran & Manal Mohammed. (2020) A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception. Current Enzyme Inhibition 16:2, pages 115-134.
Crossref
Crossref
WISHRAWANA RATNAYAKE, CHRISTOPHER APOSTOLATOS, SLOAN BREEDY & MILDRED ACEVEDO‑DUNCAN. (2020) c‑Jun and FOXO1 mediate the expression of oncogenic PKC‑ι in human prostate cancer cells with an interplay between NF‑κB, IL‑8 and ICAM‑1. World Academy of Sciences Journal.
Crossref
Crossref
Ngoc Bao To, Yen Thi-Kim Nguyen, Jeong Yong Moon, Meran Keshawa Ediriweera & Somi Kim Cho. (2020) Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling. Nutrients 12:6, pages 1663.
Crossref
Crossref
Sevda Jafari, Afsaneh Lavasanifar, Mohammad Saied Hejazi, Nasrin Maleki-Dizaji, Mehran Mesgari & Ommoleila Molavi. (2020) STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells. DARU Journal of Pharmaceutical Sciences 28:1, pages 159-169.
Crossref
Crossref
Xin Qi, Meng Li, Xiao-min Zhang, Xiu-fen Dai, Jian Cui, De-hai Li, Qian-qun Gu, Zhi-hua Lv & Jing Li. (2020) Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3. Molecules 25:10, pages 2306.
Crossref
Crossref
Fukiko Nishisaka, Keisuke Taniguchi, Momomi Tsugane, Genya Hirata, Akimitsu Takagi, Naoyuki Asakawa, Akinobu Kurita, Hiroyuki Takahashi, Naohisa Ogo, Yoshiyuki Shishido & Akira Asai. (2020) Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO‐1701. Cancer Science 111:5, pages 1774-1784.
Crossref
Crossref
Yongjing Xiang, Qing Zhang, Shujun Wei, Cong Huang, Zhengsheng Li & Yongxiang Gao. (2020)
Paeoniflorin: a monoterpene glycoside from plants of
Paeoniaceae
family with diverse anticancer activities
. Journal of Pharmacy and Pharmacology 72:4, pages 483-495.
Crossref
Crossref
Zhuan‐Yi Yang, Ying Wang, Qing Liu & Ming Wu. (2019) microRNA cluster MC‐let‐7a‐1~let‐7d promotes autophagy and apoptosis of glioma cells by down‐regulating STAT3. CNS Neuroscience & Therapeutics 26:3, pages 319-331.
Crossref
Crossref
Sangeetha Venugopal, Michal Bar-Natan & John O. Mascarenhas. (2020) JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia. Blood Reviews 40, pages 100634.
Crossref
Crossref
Büsra Öztürk Akcora, Alexandros Vassilios Gabriël, Ana Ortiz‐Perez & Ruchi Bansal. (2020) Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells. FASEB BioAdvances 2:2, pages 77-89.
Crossref
Crossref
Marie Brachet-Botineau, Marion Polomski, Heidi Neubauer, Ludovic Juen, Damien Hédou, Marie-Claude Viaud-Massuard, Gildas Prié & Fabrice Gouilleux. (2020) Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers. Cancers 12:1, pages 240.
Crossref
Crossref
Sundas Arshad, Muhammad Naveed, Mahad Ullia, Khadija Javed, Ayesha Butt, Masooma Khawar & Fazeeha Amjad. (2020) Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges. Genetics and Molecular Biology 43:1.
Crossref
Crossref
Zhe Liu, Xianmin Ge, Yuchen Gu, Yingying Huang, Hao Liu, Meiling Yu & Yamin Liu. (2020) Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo. Biomedicine & Pharmacotherapy 121, pages 109502.
Crossref
Crossref
Sujatha Peela, Dariya Begum & Ganji Purnachandra Nagaraju. 2020. Novel therapeutic approaches for gastrointestinal malignancies. Novel therapeutic approaches for gastrointestinal malignancies
193
207
.
Karolina Swiatek-Machado & Bozena Kaminska. 2020. Glioma Signaling. Glioma Signaling
203
222
.
Yan Liu, Yingru Zhi, Haizhu Song, Mingzhu Zong, Jun Yi, Guoxin Mao, Longbang Chen & Guichun Huang. (2019) S1PR1 promotes proliferation and inhibits apoptosis of esophageal squamous cell carcinoma through activating STAT3 pathway. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Sarita Saraswati, Abdulqader Alhaider, Abdelgalil Mohamed Abdelgadir, Pooja Tanwer & Hesham M. Korashy. (2019) Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1–mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma. Cell Communication and Signaling 17:1.
Crossref
Crossref
Heng-Wei Liu, Peter Mingjui Lee, Oluwaseun Adebayo Bamodu, Yu-Kai Su, Iat-Hang Fong, Chi-Tai Yeh, Ming-Hsien Chien, I-Hung Kan & Chien-Min Lin. (2019) Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in STAT3/5A-Addicted Glioblastoma. Cancers 11:12, pages 1888.
Crossref
Crossref
Phei Er Saw & Er-Wei Song. (2019) Phage display screening of therapeutic peptide for cancer targeting and therapy. Protein & Cell 10:11, pages 787-807.
Crossref
Crossref
Munmi Majumder, Shibjyoti Debnath, Rahul L. Gajbhiye, Rimpi Saikia, Bhaskarjyoti Gogoi, Suman Kumar Samanta, Deepjyoti K. Das, Kaushik Biswas, Parasuraman Jaisankar & Rupak Mukhopadhyay. (2019) Ricinus communis L. fruit extract inhibits migration/invasion, induces apoptosis in breast cancer cells and arrests tumor progression in vivo. Scientific Reports 9:1.
Crossref
Crossref
Xuebao Wang, Qin He, Kaiqi Wu, Taoning Guo, Xuze Du, Huan Zhang, Longcheng Fang, Nan Zheng, Qihong Zhang & Faqing Ye. (2019) Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3. European Journal of Medicinal Chemistry 179, pages 218-232.
Crossref
Crossref
Qi-Zhe Gong, Di Xiao, Gui-Yi Gong, Jian Xu, Xiao-Dong Wen, Feng Feng & Wei Qu. (2019) EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway. Current Cancer Drug Targets 19:7, pages 583-593.
Crossref
Crossref
Mohsen Rashid, Forough Sanjarin & Farzaneh Sabouni. (2019) Thymoquinone Effects on Cell Viability, Apoptosis and VEGF-A Gene Expression Level in AGS(CRL-1739) Cell Line. Anti-Cancer Agents in Medicinal Chemistry 19:6, pages 820-826.
Crossref
Crossref
David W. Waters, Kaj E. C. Blokland, Prabuddha S. Pathinayake, Lan Wei, Michael Schuliga, Jade Jaffar, Glen P. Westall, Philip M. Hansbro, Cecilia M. Prele, Steven E. Mutsaers, Nathan W. Bartlett, Janette K. Burgess, Christopher L. Grainge & Darryl A. Knight. (2019) STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology 61:1, pages 61-73.
Crossref
Crossref
Bing‐Dong Zhang, Yue‐Rui Li, Li‐Dan Ding, Yin‐Yin Wang, Hong‐Yi Liu & Bao‐Qing Jia. (2019) Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer. Cancer Science 110:7, pages 2258-2272.
Crossref
Crossref
Stella Sravanthi V.Bhagath Kumar Palaka, Gnana vel, Rengarajan Venkatesan, Dinakara Rao Ampasala & Latha Periyasamy. (2019) Identification of novel inhibitors of signal transducer and activator of transcription 3 over signal transducer and activator of transcription 1 for the treatment of breast cancer by in-silico and in-vitro approach. Process Biochemistry 82, pages 153-166.
Crossref
Crossref
Moon Kyung Joo, Jong-Jae Park & Hoon Jai Chun. (2019) Proton pump inhibitor: The dual role in gastric cancer. World Journal of Gastroenterology 25:17, pages 2058-2070.
Crossref
Crossref
Eun Ji Lee, Su-Jung Kim, Young-Il Hahn, Hyo-Jin Yoon, Bitnara Han, Kyeojin Kim, Seungbeom Lee, Kwang Pyo Kim, Young Ger Suh, Hye-Kyung Na & Young-Joon Surh. (2019) 15-Keto prostaglandin E2 suppresses STAT3 signaling and inhibits breast cancer cell growth and progression. Redox Biology 23, pages 101175.
Crossref
Crossref
Hui-Xiang Zhang, Ping-Lian Yang, En-Min Li & Li-Yan Xu. (2019) STAT3beta, a distinct isoform from STAT3. The International Journal of Biochemistry & Cell Biology 110, pages 130-139.
Crossref
Crossref
Akash Ahujaa, Mi-Yeon Kim & Jae Youl Cho. (2019)
Protium javanicum
Burm. Methanol Extract Attenuates LPS-Induced Inflammatory Activities in Macrophage-Like RAW264.7 Cells
. Evidence-Based Complementary and Alternative Medicine 2019, pages 1-12.
Crossref
Crossref
Shengling Fu, Xiang Chen, Hui-Wen Lo & Jiayuh Lin. (2019) Combined bazedoxifene and paclitaxel treatments inhibit cell viability, cell migration, colony formation, and tumor growth and induce apoptosis in breast cancer. Cancer Letters 448, pages 11-19.
Crossref
Crossref
Cintia Carla da Hora, Kelsey Pinkham, Litia Carvalho, Max Zinter, Elie Tabet, Ichiro Nakano, Bakhos A. Tannous & Christian E. Badr. (2019) Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition. Cell Death Discovery 5:1.
Crossref
Crossref
Haiyan Ma, Dan Yan, Yina Wang, Wei Shi, Tianshu Liu, Chongqiang Zhao, Shengqi Huo, Jialin Duan, Jingwen Tao, Maocai Zhai, Pengcheng Luo, Junyi Guo, Lei Tian, Lulu Mageta, David Jou, Cuntai Zhang, Chenglong Li, Jiayuh Lin, Jiagao Lv, Sheng Li & Li Lin. (2019) Bazedoxifene exhibits growth suppressive activity by targeting interleukin‐6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. Cancer Science 110:3, pages 950-961.
Crossref
Crossref
Jiaomei Li, Kelei Li, Jinlong Gao, Xiaofei Guo, Mengqing Lu, Zihao Li & Duo Li. (2019)
Endogenously Synthesized n‐3 Polyunsaturated Fatty Acids in Pregnant
fat‐1
Mice Decreases Mammary Cancer Risk of Female Offspring by Regulating Expression of Long Noncoding RNAs
. Molecular Nutrition & Food Research 63:6.
Crossref
Crossref
Anil Yadav, Vinoth Kumar, David Bailey & Byeong-Churl Jang. (2019) AZD1208, a Pan-Pim Kinase Inhibitor, Has Anti-Growth Effect on 93T449 Human Liposarcoma Cells via Control of the Expression and Phosphorylation of Pim-3, mTOR, 4EBP-1, S6, STAT-3 and AMPK. International Journal of Molecular Sciences 20:2, pages 363.
Crossref
Crossref
Denisa Baci, Matteo Gallazzi, Caterina Cascini, Matilde Tramacere, Daniela De Stefano, Antonino Bruno, Douglas Noonan & Adriana Albini. (2019) Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways in Prostate Cancer Cells by a Polyphenol-Rich Extract from Olive Mill Wastewater. International Journal of Molecular Sciences 20:2, pages 307.
Crossref
Crossref
Wishrawana S. Ratnayake, Christopher A. Apostolatos & Mildred Acevedo-Duncan. 2019. Cutaneous Melanoma [Working Title]. Cutaneous Melanoma [Working Title].
Lucia Unger, Vidhya Jagannathan, Alicja Pacholewska, Tosso Leeb & Vinzenz Gerber. (2018) Differences in miRNA differential expression in whole blood between horses with sarcoid regression and progression. Journal of Veterinary Internal Medicine 33:1, pages 241-250.
Crossref
Crossref
David S. Lee, Jennifer R. Grandis & Daniel E. Johnson. 2019. Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. Targeting Cell Survival Pathways to Enhance Response to Chemotherapy
145
167
.
WISHRAWANA RATNAYAKE, CHRISTOPHER APOSTOLATOS, SLOAN BREEDY, ANDRE APOSTOLATOS & MILDRED ACEVEDO-DUNCAN. (2018) FOXO1 regulates oncogenic PKC-ι expression in melanoma inversely to c-Jun in an autocrine manner via IL-17E and ICAM-1 activation. World Academy of Sciences Journal.
Crossref
Crossref
Jin Sung Koh, Moon Kyung Joo, Jong-Jae Park, Hyo Soon Yoo, Byung Il Choi, Beom Jae Lee, Hoon Jai Chun & Sang Woo Lee. (2018) Inhibition of STAT3 in gastric cancer: role of pantoprazole as SHP-1 inducer. Cell & Bioscience 8:1.
Crossref
Crossref
Sung Ho Kim, Hyo Soon Yoo, Moon Kyung Joo, Taehyun Kim, Jong-Jae Park, Beom Jae Lee, Hoon Jai Chun, Sang Woo Lee & Young-Tae Bak. (2018) Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells. BMC Cancer 18:1.
Crossref
Crossref
Aws Alshamsan. (2018) STAT3-siRNA induced B16.F10 melanoma cell death: more association with VEGF downregulation than p-STAT3 knockdown. Saudi Pharmaceutical Journal 26:8, pages 1083-1088.
Crossref
Crossref
Ali Masjedi, Vida Hashemi, Mohammad Hojjat-Farsangi, Ghasem Ghalamfarsa, Gholamreza Azizi, Mehdi Yousefi & Farhad Jadidi-Niaragh. (2018) The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomedicine & Pharmacotherapy 108, pages 1415-1424.
Crossref
Crossref
Xuanxuan Dai, Changtian Yin, Guilong Guo, Yi Zhang, Chenguang Zhao, Jianchang Qian, Ouchen Wang, Xiaohua Zhang & Guang Liang. (2018) Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3. Toxicology and Applied Pharmacology 358, pages 110-119.
Crossref
Crossref
Jenny D. Beebe, Jing-Yuan Liu & Jian-Ting Zhang. (2018) Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?. Pharmacology & Therapeutics 191, pages 74-91.
Crossref
Crossref
Mateus S V Mota, William P Jackson, Sarah K Bailey, Praveen Vayalil, Aimee Landar, Jack W RostasIIIIII, Madhuri S Mulekar, Rajeev S Samant & Lalita A Shevde. (2018) Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer. Carcinogenesis 39:9, pages 1165-1175.
Crossref
Crossref
Loukik Arora, Alan Kumar, Frank Arfuso, Wee Chng & Gautam Sethi. (2018) The Role of Signal Transducer and Activator of Transcription 3 (STAT3) and Its Targeted Inhibition in Hematological Malignancies. Cancers 10:9, pages 327.
Crossref
Crossref
Wei Huang, Yuan Liu, Jun Wang, Xia Yuan, Hong-Wei Jin, Liang-Ren Zhang, Jian-Ting Zhang, Zhen-Ming Liu & Jing-Rong Cui. (2018) Small-molecule compounds targeting the STAT3 DNA-binding domain suppress survival of cisplatin-resistant human ovarian cancer cells by inducing apoptosis. European Journal of Medicinal Chemistry 157, pages 887-897.
Crossref
Crossref
Chulwon Kim, Seok-Geun Lee, Woong Mo Yang, Frank Arfuso, Jae-Young Um, Alan Prem Kumar, Jinsong Bian, Gautam Sethi & Kwang Seok Ahn. (2018) Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model. Cancer Letters 431, pages 123-141.
Crossref
Crossref
Le Wang, Xiangwen Zhan, Xiaomeng Shen, Mingzhe Li, Jianming Yang, Wenhua Yu, Hao Chen, Bo Jin & Zebin Mao. (2018) P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling. Molecular and Cellular Biochemistry 446:1-2, pages 137-148.
Crossref
Crossref
Ying Wang, Pengjun Zhou, Shurong Qin, Dandan Xu, Yukun Liu, Wuyu Fu, Bibo Ruan, Li Zhang, Yi Zhang, Xiao Wang, Yuwei Pan, Sheng Wang, Haizhao Yan, Jinhong Qin, Xiaoyan Wang, Qiuying Liu, Zhiyun Du, Zhong Liu & Yifei Wang. (2018) The Curcumin Analogs 2-Pyridyl Cyclohexanone Induce Apoptosis via Inhibition of the JAK2–STAT3 Pathway in Human Esophageal Squamous Cell Carcinoma Cells. Frontiers in Pharmacology 9.
Crossref
Crossref
David W. Waters, Kaj E. C. Blokland, Prabuddha S. Pathinayake, Janette K. Burgess, Steven E. Mutsaers, Cecilia M. Prele, Michael Schuliga, Christopher L. Grainge & Darryl A. Knight. (2018) Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology 315:2, pages L162-L172.
Crossref
Crossref
Hauke Löcken, Cinzia Clamor & Klaus Müller. (2018) Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells. Journal of Natural Products 81:7, pages 1636-1644.
Crossref
Crossref
Man-Sai Acon-Chan, Francisco Siles-Canales & Rodrigo Mora-Rodriguez. (2018) Modeling Gene Dosage Compensation Mediated by Sensor Loops in Large-Scale Mathematical Models of Microrna-Transcription Factor Networks. Modeling Gene Dosage Compensation Mediated by Sensor Loops in Large-Scale Mathematical Models of Microrna-Transcription Factor Networks.
Mercedes Rincon & Felipe Pereira. (2018) A New Perspective: Mitochondrial Stat3 as a Regulator for Lymphocyte Function. International Journal of Molecular Sciences 19:6, pages 1656.
Crossref
Crossref
Kai Shi, Yan Fang, Shan Gao, Dongjuan Yang, Hongshu Bi, Jianxiu Xue, Anqi Lu, Yuai Li, Liyuan Ke, Xiaojie Lin, Xuechao Jin & Min Li. (2018) Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R. Journal of Controlled Release 279, pages 53-68.
Crossref
Crossref
Sara Verdura, Elisabet Cuyàs, Laura Llorach-Parés, Almudena Pérez-Sánchez, Vicente Micol, Alfons Nonell-Canals, Jorge Joven, Manuel Valiente, Melchor Sánchez-Martínez, Joaquim Bosch-Barrera & Javier A. Menendez. (2018) Silibinin is a direct inhibitor of STAT3. Food and Chemical Toxicology 116, pages 161-172.
Crossref
Crossref
Jacopo Sgrignani, Maura Garofalo, Milos Matkovic, Jessica Merulla, Carlo V. Catapano & Andrea Cavalli. (2018) Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development. International Journal of Molecular Sciences 19:6, pages 1591.
Crossref
Crossref
Raymond S. Oh, Andrew J. Haak, Karry M. J. Smith, Giovanni Ligresti, Kyoung Moo Choi, Tiao Xie, Shaohua Wang, Paula R. Walters, Michael A. Thompson, Michelle R. Freeman, Logan J. Manlove, Vivian M. Chu, Carol Feghali-Bostwick, Anja C. Roden, Jürgen Schymeinsky, Christina M. Pabelick, Y. S. Prakash, Robert Vassallo & Daniel J. Tschumperlin. (2018) RNAi screening identifies a mechanosensitive ROCK-JAK2-STAT3 network central to myofibroblast activation. Journal of Cell Science 131:10.
Crossref
Crossref
Yin Shi, Zhen Zhang, Xintao Qu, Xiaoxiao Zhu, Lin Zhao, Ran Wei, Qiang Guo, Linlin Sun, Xunqiang Yin, Yunhong Zhang & Xia Li. (2018) Roles of STAT3 in leukemia (Review). International Journal of Oncology.
Crossref
Crossref
Shirin Hasan, Afsar R. Naqvi & Asim Rizvi. (2018) Transcriptional Regulation of Emergency Granulopoiesis in Leukemia. Frontiers in Immunology 9.
Crossref
Crossref
Francisco Lopez-Tapia, Christine Brotherton-Pleiss, Peibin Yue, Heide Murakami, Ana Carolina Costa Araujo, Bruna Reis dos Santos, Erin Ichinotsubo, Anna Rabkin, Raj Shah, Megan Lantz, Suzie Chen, Marcus A. Tius & James Turkson. (2018) Linker Variation and Structure–Activity Relationship Analyses of Carboxylic Acid-based Small Molecule STAT3 Inhibitors. ACS Medicinal Chemistry Letters 9:3, pages 250-255.
Crossref
Crossref
Yena Jin, Young Hwan Kim, Jin Yong Park, Yu-Jin Lee, Hyun-Mi Oh, Sung-Kyu Choi, Dong Cho Han & Byoung-Mog Kwon. (2018) Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells. Bioorganic & Medicinal Chemistry Letters 28:5, pages 853-857.
Crossref
Crossref
Md. Abdullah Al Noman, Tasnova Hossain, Monira Ahsan, Shirin JamshidiChoudhury Mahmood Hasan & Khondaker Miraz Rahman. (2018)
Crispenes F and G,
cis
-Clerodane Furanoditerpenoids from
Tinospora crispa
, Inhibit STAT3 Dimerization
. Journal of Natural Products 81:2, pages 236-242.
Crossref
Crossref
Amara Maryam, Tahir Mehmood, Qiulong Yan, Yongming Li, Muhammad Khan & Tonghui Ma. (2018) Proscillaridin A Promotes Oxidative Stress and ER Stress, Inhibits STAT3 Activation, and Induces Apoptosis in A549 Lung Adenocarcinoma Cells. Oxidative Medicine and Cellular Longevity 2018, pages 1-17.
Crossref
Crossref
Arif Khan. 2018. Molecular and Therapeutic actions of Thymoquinone. Molecular and Therapeutic actions of Thymoquinone
41
56
.
Yu-Tang Chin, Le-Ming Wang, Meng-Ti Hsieh, Ya-Jung Shih, André Wendindondé Nana, Chun A. Changou, Yu-Chen S. H. Yang, Hsien-Chung Chiu, Earl Fu, Paul J. Davis, Heng-Yuan Tang & Hung-Yun Lin. (2017) Leptin OB3 peptide suppresses leptin-induced signaling and progression in ovarian cancer cells. Journal of Biomedical Science 24:1.
Crossref
Crossref
Zachary Speth, Tanzila Islam, Kasturi Banerjee & Haluk Resat. (2017) EGFR signaling pathways are wired differently in normal 184A1L5 human mammary epithelial and MDA-MB-231 breast cancer cells. Journal of Cell Communication and Signaling 11:4, pages 341-356.
Crossref
Crossref
Jin Han Nam, Hyun‐Ji Cho, Hyejin Kang, Ju‐Young Lee, Mira Jung, Young‐Chae Chang, Keetae Kim & Hyang‐Sook Hoe. (2017) A Mercaptoacetamide‐Based Class II Histone Deacetylase Inhibitor Suppresses Cell Migration and Invasion in Monomorphic Malignant Human Glioma Cells by Inhibiting FAK/STAT3 Signaling. Journal of Cellular Biochemistry 118:12, pages 4672-4685.
Crossref
Crossref
Amir Sonnenblick, Roberto Salgado, Sylvain Broh�e, Tamar Zahavi, Tamar Peretz, Gert Van den Eynden, Ghizlane Rouas, Asher Salmon, Prudence Francis, Angelo Di Leo, John Crown, Giuseppe Viale, Laura Daly, Bahar Javdan, Sho Fujisawa, Evandro De Azambuja, Ameye Lieveke, Martine Piccart, Jacqueline Bromberg & Christos Sotiriou. (2017) p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial. International Journal of Oncology.
Crossref
Crossref
Debomita Chakraborty, Barbora Šumová, Tatjana Mallano, Chih-Wei Chen, Alfiya Distler, Christina Bergmann, Ingo Ludolph, Raymund E. Horch, Kolja Gelse, Andreas Ramming, Oliver Distler, Georg Schett, Ladislav Šenolt & Jörg H. W. Distler. (2017) Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis. Nature Communications 8:1.
Crossref
Crossref
S Sengupta, A Nagalingam, N Muniraj, M Y Bonner, P Mistriotis, A Afthinos, P Kuppusamy, D Lanoue, S Cho, P Korangath, M Shriver, A Begum, V F Merino, C-Y Huang, J L Arbiser, W Matsui, B Győrffy, K Konstantopoulos, S Sukumar, P A Marignani, N K Saxena & D Sharma. (2017) Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3. Oncogene 36:41, pages 5709-5721.
Crossref
Crossref
Sehamuddin Galadari, Anees Rahman, Siraj Pallichankandy & Faisal Thayyullathil. (2017) Molecular targets and anticancer potential of sanguinarine—a benzophenanthridine alkaloid. Phytomedicine 34, pages 143-153.
Crossref
Crossref
Mengting Tong, Jing Wang, Nanyu Jiang, Hongming Pan & Da Li. (2017) Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis. PLOS ONE 12:8, pages e0182282.
Crossref
Crossref
Deung Dae Park, Hye-Won Yum, Xiancai Zhong, Seung Hyeon Kim, Seong Hoon Kim, Do-Hee Kim, Su-Jung Kim, Hye-Kyung Na, Atsuya Sato, Takehito Miura & Young-Joon Surh. (2017) Perilla frutescens Extracts Protects against Dextran Sulfate Sodium-Induced Murine Colitis: NF-κB, STAT3, and Nrf2 as Putative Targets. Frontiers in Pharmacology 8.
Crossref
Crossref
Nakho Chang, Sun Hee Ahn, Doo-Sik Kong, Hye Won Lee & Do-Hyun Nam. (2017) The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment. Molecular and Cellular Endocrinology 451, pages 53-65.
Crossref
Crossref
Peter Y. Yu, Heather L. Gardner, Ryan Roberts, Hakan Cam, Seethalakshmi Hariharan, Ling Ren, Amy K. LeBlanc, Hui Xiao, Jiayuh Lin, Denis C. Guttridge, Xiaokui Mo, Chad E. Bennett, Christopher C. Coss, Yonghua Ling, Mitch A. Phelps, Peter Houghton & Cheryl A. London. (2017) Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PLOS ONE 12:7, pages e0181885.
Crossref
Crossref
Amara Maryam, Tahir Mehmood, He Zhang, Yongming Li, Muhammad Khan & Tonghui Ma. (2017) Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Scientific Reports 7:1.
Crossref
Crossref
X Ma, Z Meng, L Jin, Z Xiao, X Wang, W M Tsark, L Ding, Y Gu, J Zhang, B Kim, M He, X Gan, J E Shively, H Yu, R Xu & W Huang. (2017) CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation. Oncogene 36:28, pages 4060-4071.
Crossref
Crossref
Nicole M. Jackson & Brian P. Ceresa. (2017) EGFR-mediated apoptosis via STAT3. Experimental Cell Research 356:1, pages 93-103.
Crossref
Crossref
Malabika Sen, Paul A. Johnston, Netanya I. Pollock, Kara DeGrave, Sonali C. Joyce, Maria L. Freilino, Yun Hua, Daniel P. Camarco, David A. Close, Donna M. Huryn, Peter Wipf & Jennifer R. Grandis. (2017) Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines. Journal of Chemical Biology 10:3, pages 129-141.
Crossref
Crossref
Zhi‑Ren Zhang, Ming‑Xia Gao & Kai Yang. (2017) Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways. Experimental and Therapeutic Medicine.
Crossref
Crossref
Yiping Wen, Jing Cai, Yaya Hou, Zaiju Huang & Zehua Wang. (2017) Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target. Oncotarget 8:23, pages 37974-37990.
Crossref
Crossref
M Sarkar, V Khare & M K Ghosh. (2016) The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis. Oncogene 36:22, pages 3080-3093.
Crossref
Crossref
Yina Wang, Haiyan Ma, Chongqiang Zhao, Tianshu Liu, Dan Yan, David Jou, Huameng Li, Cuntai Zhang, Jiagao Lü, Chenglong Li, Jiayuh Lin, Sheng Li & Li Lin. (2017) Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling. Oncotarget 8:20, pages 33683-33693.
Crossref
Crossref
Edith C. Kordon & Omar A. Coso. 2017. Current Topics in Lactation. Current Topics in Lactation.
Wenying Yu, Chenglong Li, Wenda Zhang, Yuanzheng Xia, Shanshan Li, Jia-yuh Lin, Keqin Yu, Mu Liu, Lei Yang, Jianguang Luo, Yijun Chen, Hongbin Sun & Lingyi Kong. (2017) Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking. Journal of Medicinal Chemistry 60:7, pages 2718-2731.
Crossref
Crossref
Jing ChenYong ZhangMichael N. PetrusWenming XiaoAlina NicolaeMark RaffeldStefania PittalugaRichard N. BamfordMasao NakagawaSunny Tianyi OuyangAlan L. EpsteinMarshall E. KadinAnnarose Del MistroRichard Woessner, Elaine S. JaffeThomas A. Waldmann. (2017) Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proceedings of the National Academy of Sciences 114:15, pages 3975-3980.
Crossref
Crossref
Tyvette S. Hilliard, Gabriella Miklossy, Christopher Chock, Peibin Yue, Philip Williams & James Turkson. (2017)
15α-methoxypuupehenol Induces Antitumor Effects
In Vitro
and
In Vivo
against Human Glioblastoma and Breast Cancer Models
. Molecular Cancer Therapeutics 16:4, pages 601-613.
Crossref
Crossref
Ying Hu, Zihan Sun, Jinmu Deng, Baoquan Hu, Wenting Yan, Hongyi Wei & Jun Jiang. (2017) Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway. Tumor Biology 39:3, pages 101042831769431.
Crossref
Crossref
Youn Choi, Junseong Kim, Kang Lee, Yu-Jeong Choi, Bo-Ram Ye, Min-Sun Kim, Seong-Gyu Ko, Seung-Hong Lee, Do-Hyung Kang & Soo-Jin Heo. (2017) Tuberatolide B Suppresses Cancer Progression by Promoting ROS-Mediated Inhibition of STAT3 Signaling. Marine Drugs 15:3, pages 55.
Crossref
Crossref
Dagmar Gotthardt & Veronika Sexl. (2017) STATs in NK-Cells: The Good, the Bad, and the Ugly. Frontiers in Immunology 7.
Crossref
Crossref
Wen ChengChuanbao ZhangXiufang RenYang JiangSheng HanYang LiuJinquan CaiMingyang LiKuanyu WangYanwei LiuHuimin HuQingbin LiPei YangZhaoshi BaoAnhua Wu. (2017) Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma. Journal of Neurosurgery 126:1, pages 249-259.
Crossref
Crossref
Chulwon Kim, Sang Hyun Baek, Jae-Young Um, Bum Sang Shim & Kwang Seok Ahn. (2016) Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma. BMC Nephrology 17:1.
Crossref
Crossref
Zhaoxing Dong, Wenlin Tai, Wen Lei, Yin Wang, ZhenKun Li & Tao Zhang. (2016) IL-27 inhibits the TGF-?1-induced epithelial-mesenchymal transition in alveolar epithelial cells. BMC Cell Biology 17:1.
Crossref
Crossref
Min Huang, Zhongjie Chen, Lu Zhang, Zhimin Huang, Yiying Chen, Jianrong Xu, Jian Zhang & Xiaohong Shu. (2016) Screening and biological evaluation of a novel STAT3 signaling pathway inhibitor against cancer. Bioorganic & Medicinal Chemistry Letters 26:21, pages 5172-5176.
Crossref
Crossref
Steffanie L. Furtek, Christopher J. Matheson, Donald S. Backos & Philip Reigan. (2016) Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors. Oncotarget 7:47, pages 77998-78008.
Crossref
Crossref
Neeraj Kumari, B. S. Dwarakanath, Asmita Das & Anant Narayan Bhatt. (2016) Role of interleukin-6 in cancer progression and therapeutic resistance. Tumor Biology 37:9, pages 11553-11572.
Crossref
Crossref
Arati A. Inamdar, Andre Goy, Nehad M. Ayoub, Christen Attia, Lucia Oton, Varun Taruvai, Mark Costales, Yu-Ting Lin, Andrew Pecora & K. Stephen Suh. (2016) Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Oncotarget 7:30, pages 48692-48731.
Crossref
Crossref
Yunqin Lee, June Ho Shin, Michelle Longmire, Hua Wang, Holbrook E. Kohrt, Howard Y. Chang & John B. Sunwoo. (2016) CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell–Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1. Clinical Cancer Research 22:14, pages 3571-3581.
Crossref
Crossref
Yi Qin, Zhi-Wei Liao, Jing-Yan Luo, Wen-Zhe Wu, An-Shang Lu, Pu-Xia Su, Bing-Quan Lai & Xiao-Xiao Wang. (2016) Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis. Tumor Biology 37:7, pages 9273-9283.
Crossref
Crossref
Baoying Hu, Xia Yan, Fang Liu, Changlai Zhu, Huiling Zhou, Yuyan Chen, Jinxia Liu, Xingxing Gu, Runzhou Ni & Tianyi Zhang. (2015) Downregulated Expression of PTPN9 Contributes to Human Hepatocellular Carcinoma Growth and Progression. Pathology & Oncology Research 22:3, pages 555-565.
Crossref
Crossref
Teresa A. Zimmers, Melissa L. Fishel & Andrea Bonetto. (2016) STAT3 in the systemic inflammation of cancer cachexia. Seminars in Cell & Developmental Biology 54, pages 28-41.
Crossref
Crossref
Bruna R. Rodrigues, Nicolle Queiroz-Hazarbassanov, Marilene H. Lopes, Luis F. Bleggi-Torres, S?rgio Suzuki, Isabela W. Cunha, Paulo Sanematsu & Vilma R. Martins. (2016) Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma. Pathology - Research and Practice 212:6, pages 517-523.
Crossref
Crossref
Kasturi Banerjee & Haluk Resat. (2016) Constitutive activation of STAT3 in breast cancer cells: A review. International Journal of Cancer 138:11, pages 2570-2578.
Crossref
Crossref
Zilma Escobar, Anders Bjartell, Giacomo Canesin, Susan Evans-Axelsson, Olov Sterner, Rebecka Hellsten & Martin H Johansson. (2016)
Preclinical Characterization of 3β-(
N
-Acetyl
l
-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer
. Journal of Medicinal Chemistry 59:10, pages 4551-4562.
Crossref
Crossref
Silvia Novío, María Cartea, Pilar Soengas, Manuel Freire-Garabal & María Núñez-Iglesias. (2016) Effects of Brassicaceae Isothiocyanates on Prostate Cancer. Molecules 21:5, pages 626.
Crossref
Crossref
Jessica L. Geiger, Jennifer R. Grandis & Julie E. Bauman. (2016) The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations. Oral Oncology 56, pages 84-92.
Crossref
Crossref
Jennifer E. Yeh & David A. Frank. (2016) STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy. ChemMedChem 11:8, pages 795-801.
Crossref
Crossref
Sunmi Park & Hyun-Seuk Moon. (2016) Anti-proliferative Effects of Celastrol, A Quinine Methide Triterpene Extracted from the Perennial Vine Tripterygium wilfordii, on Obesity-related Cancers. Journal of Food Hygiene and Safety 31:1, pages 59-66.
Crossref
Crossref
Steffanie L. Furtek, Donald S. Backos, Christopher J. Matheson & Philip Reigan. (2016) Strategies and Approaches of Targeting STAT3 for Cancer Treatment. ACS Chemical Biology 11:2, pages 308-318.
Crossref
Crossref
Erick Riquelme, Carmen Behrens, Heather Y. Lin, George Simon, Vassiliki Papadimitrakopoulou, Julie Izzo, Cesar Moran, Neda Kalhor, J. Jack Lee, John D. Minna & Ignacio I. Wistuba. (2016) Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations. Cancer Research 76:3, pages 675-685.
Crossref
Crossref
Peibin Yue, Francisco Lopez-Tapia, David Paladino, Yifei Li, Chih-Hong Chen, Andrew T. Namanja, Tyvette Hilliard, Yuan Chen, Marcus A. Tius & James Turkson. (2016)
Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes
In Vitro
and
In Vivo
. Cancer Research 76:3, pages 652-663.
Crossref
Crossref
W Huang, Z Dong, Y Chen, F Wang, C J Wang, H Peng, Y He, G Hangoc, K Pollok, G Sandusky, X-Y Fu, H E Broxmeyer, Z-Y Zhang, J-Y Liu & J-T Zhang. (2015) Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo. Oncogene 35:6, pages 783-792.
Crossref
Crossref
Yinglong Zhang, Qiong Ma, Tao Liu, Guofeng Guan, Kailiang Zhang, Jiayan Chen, Nan Jia, Shiju Yan, Guanyin Chen, Shiluan Liu, Kuo Jiang, Yao Lu, Yanhua Wen, Haien Zhao, Yong Zhou, Qingyu Fan & Xiuchun Qiu. (2015) Interleukin-6 suppression reduces tumour self-seeding by circulating tumour cells in a human osteosarcoma nude mouse model. Oncotarget 7:1, pages 446-458.
Crossref
Crossref
Uddalak Bharadwaj, Moses M. Kasembeli & David J. Tweardy. 2016. STAT Inhibitors in Cancer. STAT Inhibitors in Cancer
95
161
.
Hui-Wen Lue, Brook Cole, Soumya A. M. Rao, Jennifer Podolak, Ahna Van Gaest, Carly King, Christopher A. Eide, Beth Wilmot, Changhui Xue, Paul T. Spellman, Laura M. Heiser, Jeffrey W. Tyner & George V. Thomas. (2015) Src and STAT3 inhibitors synergize to promote tumor inhibition in renal cell carcinoma. Oncotarget 6:42, pages 44675-44687.
Crossref
Crossref
Maximilian Niit, Victoria Hoskin, Esther Carefoot, Mulu Geletu, Rozanne Arulanandam, Bruce Elliott & Leda Raptis. (2015) Cell-cell and cell-matrix adhesion in survival and metastasis: Stat3 versus Akt. Biomolecular Concepts 6:5-6, pages 383-399.
Crossref
Crossref
Ji Hoon Phi, Seung-Ah Choi, Seung-Ki Kim, Kyu-Chang Wang, Ji Yeoun Lee & Dong Gyu Kim. (2015) Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling. Translational Oncology 8:5, pages 376-386.
Crossref
Crossref
Muthu K. Shanmugam, Peramaiyan Rajendran, Feng Li, Chulwon Kim, Sakshi Sikka, Kodappully Sivaraman Siveen, Alan Prem Kumar, Kwang Seok Ahn & Gautam Sethi. (2015) Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model. Molecular Carcinogenesis 54:10, pages 971-985.
Crossref
Crossref
Tao Han, Dai-Min Xiang, Wen Sun, Na Liu, Huan-Lin Sun, Wen Wen, Wei-Feng Shen, Ruo-Yu Wang, Cheng Chen, Xue Wang, Zhuo Cheng, Heng-Yu Li, Meng-Chao Wu, Wen-Ming Cong, Gen-Sheng Feng, Jin Ding & Hong-Yang Wang. (2015) PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients. Journal of Hepatology 63:3, pages 651-660.
Crossref
Crossref
Divya Singh, Ghanshyam Upadhyay, Rakesh K. Srivastava & Sharmila Shankar. (2015) Recent advances in pancreatic cancer: biology, treatment, and prevention. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1856:1, pages 13-27.
Crossref
Crossref
Pushpendra Singh & Felix Bast. (2015) High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of signal transducer and activator of transcription 3. Medicinal Chemistry Research 24:6, pages 2694-2708.
Crossref
Crossref
A.L. Wong, R.A. Soo, D.S. Tan, S.C. Lee, J.S. Lim, P.C. Marban, L.R. Kong, Y.J. Lee, L.Z. Wang, W.L. Thuya, R. Soong, M.Q. Yee, T.M. Chin, M.T. Cordero, B.R. Asuncion, B. Pang, S. Pervaiz, J.L. Hirpara, A. Sinha, W.W. Xu, M. Yuasa, T. Tsunoda, M. Motoyama, T. Yamauchi & B.C. Goh. (2015) Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies. Annals of Oncology 26:5, pages 998-1005.
Crossref
Crossref
Cuiqi Zhou, Yonghui Jiao, Renzhi Wang, Song-Guang Ren, Kolja Wawrowsky & Shlomo Melmed. (2015) STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion. Journal of Clinical Investigation 125:4, pages 1692-1702.
Crossref
Crossref
Galina Gritsina, Fang Xiao, Shane W. O'Brien, Rashid Gabbasov, Marisa A. Maglaty, Ren-Huan Xu, Roshan J. Thapa, Yan Zhou, Emmanuelle Nicolas, Samuel Litwin, Siddharth Balachandran, Luis J. Sigal, Dennis Huszar & Denise C. Connolly. (2015) Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth. Molecular Cancer Therapeutics 14:4, pages 1035-1047.
Crossref
Crossref
Hong Liu, Guoping Ren, Tingyang Wang, Yuexia Chen, Chaoju Gong, Yanfeng Bai, Bo Wang, Hongyan Qi, Jing Shen, Lijun Zhu, Cheng Qian, Maode Lai & Jimin Shao. (2015) Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial–mesenchymal transition. Carcinogenesis 36:4, pages 459-468.
Crossref
Crossref
Malabika Sen, Netanya I. Pollock, John Black, Kara A. DeGrave, Sarah Wheeler, Maria L. Freilino, Sonali Joyce, Vivian W.Y. Lui, Yan Zeng, Simion I. Chiosea & Jennifer R. Grandis. (2015) JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth. Neoplasia 17:3, pages 256-264.
Crossref
Crossref
Xiaoshen Sun, Zainul S. Hasanali, Allshine Chen, Dianzheng Zhang, Xin Liu, Hong-Gang Wang, David J. Feith, Thomas P. LoughranJrJr & Kailin Xu. (2015) Suberoylanilide hydroxamic acid (SAHA) and cladribine synergistically induce apoptosis in NK-LGL leukaemia. British Journal of Haematology 168:3, pages 371-383.
Crossref
Crossref
Brent J. Tierney, Georgia A. McCann, Shan Naidu, Kellie S. Rath, Uksha Saini, Ross Wanner, Periannan Kuppusamy, Adrian Suarez, Paul J. Goodfellow, David E. Cohn & Karuppaiyah Selvendiran. (2014) Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor. Gynecologic Oncology 135:1, pages 133-141.
Crossref
Crossref
Melanie Spitzner, Reinhard Ebner, Hendrik Wolff, B. Ghadimi, Jürgen Wienands & Marian Grade. (2014) STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy. Cancers 6:4, pages 1986-2011.
Crossref
Crossref
Robert W. Tell & Curt M. Horvath. (2014) Bioinformatic analysis reveals a pattern of STAT3-associated gene expression specific to basal-like breast cancers in human tumors. Proceedings of the National Academy of Sciences 111:35, pages 12787-12792.
Crossref
Crossref
K S Siveen, A H Nguyen, J H Lee, F Li, S S Singh, A P Kumar, G Low, S Jha, V Tergaonkar, K S Ahn & G Sethi. (2014) Negative regulation of signal transducer and activator of transcription-3 signalling cascade by lupeol inhibits growth and induces apoptosis in hepatocellular carcinoma cells. British Journal of Cancer 111:7, pages 1327-1337.
Crossref
Crossref
Arash Falamarzian, Hamidreza Montazeri Aliabadi, Ommoleila Molavi, John M. Seubert, Raymond Lai, Hasan Uludağ & Afsaneh Lavasanifar. (2014) Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy. Journal of Biomedical Materials Research Part A 102:9, pages 3216-3228.
Crossref
Crossref
Displaying 200 of 319 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list